MicroRNA-378a-3p Modulates Inflammatory Responses of Keratinocytes to Atopic Dermatitis-Related Cytokines or Staphylococcus aureus

This study demonstrates that miR-378a-3p, which is upregulated in atopic dermatitis lesions by IL-4 and *Staphylococcus aureus*, acts as a positive regulator of keratinocyte inflammatory responses by enhancing canonical NF-κB pathway activity and amplifying innate immune cytokine secretion, thereby potentially contributing to disease exacerbation.

The Gist

The Big Picture: A Skin Alarm System Gone Haywire

Imagine your skin is a fortified castle. The outer walls are made of keratinocytes (skin cells), and their job is to keep the bad guys out and the good guys in.

In a condition called Atopic Dermatitis (AD), or eczema, this castle is under constant attack. Two main things trigger the alarm:

1. Chemical signals from the body's own immune system (like IL-4, a "Type 2" inflammation signal).
2. Invaders like Staphylococcus aureus (a common bacteria that loves to colonize eczema skin).

This study discovered a tiny, microscopic "switch" inside the skin cells called miR-378a-3p. Think of this switch as a volume knob for the skin's alarm system. The researchers found that in eczema patients, this volume knob is turned way up.

What Did the Scientists Do?

The team took healthy skin cells (the "castle guards") and artificially turned up this "volume knob" (miR-378a-3p) to see what would happen. They then poked the cells with the usual troublemakers: IL-4, IL-17, and live S. aureus bacteria.

The Surprising Findings

Here is what happened when they turned up the volume:

1. The "Volume Knob" Makes the Alarm Louder

When the cells were exposed to the bacteria (S. aureus), having this high volume knob made the cells scream much louder. They released massive amounts of inflammatory chemicals (like IL-8 and IL-1β).

• The Analogy: Imagine a smoke detector. Normally, it beeps when there's a little smoke. But with miR-378a-3p turned up, the detector doesn't just beep; it blasts a siren that wakes up the whole neighborhood, even if the fire isn't that big. This explains why eczema skin gets so red, itchy, and inflamed when bacteria are present.

2. The "Master Switch" Paradox (The NF-κB Mystery)

This is the most clever part of the discovery. Inside the cell, there is a "Master Switch" called NF-κB that controls the alarm. Usually, to turn this switch on, you need to remove a "safety lock" (a protein called IκBα).

• Previous Theory: Scientists thought miR-378a-3p worked by breaking the safety lock.
• This Study's Discovery: That wasn't what happened! Instead, miR-378a-3p did something more complex. It removed several other parts of the machine that usually slow the switch down, while simultaneously boosting the fuel for the switch.
• The Analogy: Imagine a car with a brake pedal (the safety lock). The scientists thought the microRNA was cutting the brake line. Instead, they found it was removing the weight from the car and pressing the gas pedal harder at the same time. The result? The car (the immune response) zooms forward even though the brake line is still intact.

3. The Walls Get Weaker

While the alarm was screaming, the actual walls of the castle started to crumble. The study showed that miR-378a-3p turned down the genes responsible for building strong skin barriers.

• The Analogy: While the guards are busy shouting at the intruders, they forget to repair the bricks. The wall gets thinner and weaker, making it easier for more bacteria to get in, creating a vicious cycle.

Why Does This Matter?

This research solves a puzzle: Why is eczema skin so sensitive to bacteria?

The answer is that in eczema, the skin cells have this "volume knob" (miR-378a-3p) stuck in the "High" position.

1. When bacteria show up, the skin doesn't just react; it overreacts.
2. This overreaction causes more inflammation, which damages the skin barrier.
3. The damaged barrier lets in more bacteria, which triggers the volume knob again.

The Takeaway for Everyday Life

Think of miR-378a-3p as a hyper-sensitive smoke detector in a house with a leaky roof.

• In a healthy house, the detector is quiet, and the roof is solid.
• In an eczema house, the detector is set to "Maximum Volume," and the roof is leaking.
• When a little smoke (bacteria) appears, the detector goes crazy, causing panic (inflammation) that actually makes the roof leak even more.

The Future: If doctors can find a way to turn this "volume knob" down (perhaps with a new medication), they might be able to stop the screaming alarm and let the skin heal, breaking the cycle of infection and inflammation that makes eczema so difficult to treat.

Technical Summary

1. Problem Statement

Atopic Dermatitis (AD) is a chronic inflammatory skin disease characterized by barrier dysfunction, dysregulated immune responses (particularly Th2), and frequent colonization by Staphylococcus aureus (S. aureus). While microRNAs (miRNAs) are known to regulate gene expression in AD, the specific function of miR-378a-3p in the context of AD pathogenesis remains unclear. Although miR-378a-3p is known to be upregulated in AD lesional skin and previously linked to psoriasis via IL-17A induction, its role in keratinocyte responses to AD-specific triggers (IL-4 and S. aureus) and its mechanism of action on inflammatory pathways (specifically NF-κB) had not been elucidated.

2. Methodology

The study utilized Normal Human Epidermal Keratinocytes (NHEKs) cultured in both 2D monolayers and 3D epidermal equivalents to mimic physiological conditions.

• Induction Studies: NHEKs were stimulated with AD-relevant cytokines (IL-4, IL-17A, IFN-γ) or infected with live S. aureus to measure endogenous miR-378a-3p expression via RT-qPCR.
• Functional Overexpression: NHEKs were transfected with miR-378a-3p mimics or negative control (NC) mimics using PepFect14 peptide.
• Transcriptomics: RNA sequencing (RNA-se) was performed on transfected cells under unstimulated and cytokine-stimulated conditions. Differentially Expressed Genes (DEGs) were identified (FDR < 0.05, baseMean ≥ 15).
• Bioinformatics: Gene Set Enrichment Analysis (GSEA) was conducted using Hallmark and Gene Ontology (GO) databases. Target prediction was performed using TargetScan.
• Validation:
  • mRNA: RT-qPCR for specific inflammatory mediators (CXCL8, CCL20, IL-1 family, etc.).
  • Protein: ELISA for secreted cytokines (IL-8, IL-1β, IL-1Ra).
  • Western Blot: Analysis of NF-κB pathway components (p65, RelB, c-Rel, IκBα) and phosphorylation status (p-p65).
  • Flow Cytometry: Assessment of MHC class II (HLA-DR) expression.
• S. aureus Infection Model: Transfected NHEKs were infected with live S. aureus to assess the modulation of bacterial-induced inflammation.

3. Key Contributions

• Identification of Inducers: Established that miR-378a-3p is induced not only by IL-17A (as previously known) but also by IL-4 and live S. aureus in keratinocytes, linking Type 2 inflammation and microbial exposure to miR-378a-3p upregulation.
• Mechanism of NF-κB Activation: Challenged the prevailing model that miR-378a-3p acts solely through a single dominant target (IκBα/NFKBIA). Instead, the study demonstrates that miR-378a-3p promotes canonical NF-κB activation through a coordinated modulation of multiple network components.
• Amplification of Bacterial Response: Demonstrated that miR-378a-3p specifically exacerbates the innate immune response to S. aureus colonization, a key driver of AD severity.
• Dual Role in Barrier and Immunity: Revealed that miR-378a-3p simultaneously upregulates inflammatory pathways while downregulating genes critical for epidermal development and differentiation.

4. Key Results

A. Induction and Transcriptomic Landscape

• miR-378a-3p expression was significantly upregulated by IL-4 and live S. aureus in both 2D and 3D cultures.
• Overexpression of miR-378a-3p resulted in thousands of DEGs. GSEA revealed positive enrichment of inflammatory response, TNF-α signaling via NF-κB, and KRAS signaling, while pathways related to epidermal development and differentiation were negatively enriched.
• Specific NF-κB target genes (CXCL8, CCL20, ICAM1) were consistently upregulated. Conversely, several IL-1 family cytokines (IL1B, IL18, IL33) and their antagonists were downregulated in unstimulated/cytokine-only conditions.

B. Mechanism of NF-κB Regulation

• Protein Level: Despite the upregulation of NF-κB-dependent inflammatory mediators, miR-378a-3p overexpression led to a reduction in total protein levels of NF-κB subunits (p65/RELA, c-Rel/REL, RelB) and predicted direct targets (TRAF3, TRAF6, TOLLIP).
• Activation Status: Crucially, the ratio of phosphorylated p65 (p-p65) to total p65 was significantly increased. This indicates that miR-378a-3p enhances the activation of the canonical NF-κB pathway even while reducing the abundance of the transcription factors.
• Target Specificity: Unlike previous studies in psoriasis, NFKBIA (IκBα) was not significantly downregulated in this study, suggesting a distinct mechanism where miR-378a-3p reshapes the regulatory network (e.g., upregulating CBM complex components BCL10 and CARD11) rather than simply inhibiting the inhibitor.

C. Modulation of S. aureus Response

• In the presence of live S. aureus, miR-378a-3p overexpression amplified the inflammatory response.
• This resulted in significantly increased mRNA and protein secretion of IL-8, IL-1β, and IL-1Ra compared to controls.
• This contrasts with the suppressive effect on IL-1β seen in cytokine-only conditions, highlighting that miR-378a-3p specifically potentiates inflammasome-driven responses triggered by bacterial infection.

D. Epidermal Differentiation and MHC

• Genes essential for epidermal barrier integrity (e.g., TGM1, KRT14, DSP) were downregulated. TGM1 was identified as a predicted direct target.
• miR-378a-3p enhanced IFN-γ-induced expression of MHC class II (HLA-DR), increasing the proportion of antigen-presenting keratinocytes.

5. Significance

This study redefines the role of miR-378a-3p in skin immunity:

1. Pathogenic Role in AD: It identifies miR-378a-3p as a positive regulator of keratinocyte inflammation that contributes to AD exacerbation, particularly in the context of S. aureus colonization.
2. Complex Regulatory Model: It proposes a sophisticated model where a single miRNA fine-tunes the NF-κB pathway by simultaneously suppressing upstream inhibitors/adaptors and promoting activation signals, leading to a net increase in canonical signaling.
3. Therapeutic Implications: The findings suggest that targeting miR-378a-3p could be a strategy to dampen the hyper-inflammatory response to S. aureus in AD patients and potentially restore epidermal barrier function by reversing the downregulation of differentiation markers.
4. Context-Dependent Function: The study highlights that miR-378a-3p's effect on IL-1β is context-dependent (suppressive in cytokine-only vs. amplifying in bacterial infection), underscoring the complexity of miRNA regulation in different disease microenvironments.